Funding Opportunities

The Office of the Vice Provost for Research (VPR) is pleased to announce the following funding opportunities specific to COVID-19.

This list will be updated as new opportunities arise. Last updated July 6 – 5:00 PM

DoD Funding Opportunities

DoD COVID-19 FUNDING OPPORTUNITIES

SPONSOR PROGRAM FUNDING DEADLINE
Department of Defense(DoD) Request for Information for PPE in response to COVID-19 N/A 3/24/2020 (information accepted on a rolling basis)
Internal JHU Funding Opportunities

Internal JHU COVID-19 FUNDING OPPORTUNITIES

SPONSOR PROGRAM FUNDING DEADLINE
Other Sponsor Funding Opportunities

COVID-19 FUNDING OPPORTUNITIES

SPONSOR PROGRAM FUNDING DEADLINE
COVID-19 Early Treatment Fund (CETF) Funding for Outpatient Trials Up to $1M Currently accepting applications
Cisco Pandemic/COVID19 Science, Technology and Social Impact Unspecified Unspecified
Autism Speaks COVID-19 Call for Resources N/A Unspecified
Biogen Foundation
(typically funds Boston, MA & Research Triangle, NC)
NEWCOVID-19 Response Unspecified (up to $10M in total funding) Unspecified (accepting applications)
Draper Richards Kaplan Foundation NEWDRK Covid-19 Urgent Response Initiative (CURI) $50,000 – $100,000 (CURI invests 25% maximum of total)/td> Unspecified
Merck KGaA (Germany) Research Grant for Pandemic Preparedness $1,500,000 € Applications accepted on a rolling basis
Mozilla COVID-19 Solutions Fund $50,000 Applications accepted on a rolling basis
Department of Energy (DOE) Invitation for COVID-19 scientific questions DOE Resources 3/18/2020 (reviews start 3/18 but accepted on a rolling basis)
Ferring Pharmaceuticals NEWFerring COVID-19 Investigational Grants 25,000€ 4/15/2020 (applications accepted through 10/31/2020)
Data.org (in partnership with Mastercard Center for Inclusive Growth and the Rockefeller Foundation) Inclusive Growth and Recovery Challenge $10,000 – $10M 7/17/2020
EngageZone/strong> Investigator Studies Program (MISP): SARS CoV-2/COVID-19 unspecified 7/24/2020
XPRIZE NEW2020 COVID-19 Call for Code Global Challenge $270,000 7/31/2020
Gilead NEWCOVID-19 RFP Program: COMMIT™ $250,000 8/3/2020
The Greenwall Foundation NEWMaking a Difference Request for Proposals – Fall 2020 $22M LOI: 6/24/2020
Invited full app: 8/28/2020
U.S. Department of State (DOS) NEWND-NOFO-20-111: COVID-19 Small Grants Program $100,000 9/30/2020
Biomedical Advanced Research and Development Authority (BARDA) Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Negotiated after white paper stage 10/31/2020 (white paper & full application)
Wellcome Trust & UK Department for International Development (DFID) Epidemic Preparedness: COVID-19 funding call Up to £2 million available Currently Closed
NIH Funding Opportunities

NIH COVID-19 FUNDING OPPORTUNITIES

SPONSOR PROGRAM FUNDING DEADLINE
National Institutes of Health (NIH)

NIA, NIAID, NIDDK, NIDA, NIMH, NIEHS, NICHD, NIAAA, NIBIB, NHGRI, NIMHD, NCATS, NIDCH, NCI

Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional) Must reflect your needs Varies by awarding IC
National Institutes of Health (NIH)

NIAID

Administrative Supplement Not limited 2/6/2020 (applications accepted through 2/6/2021)
National Institutes of Health (NIH)

NIGMS

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 Must reflect your needs 3/5/2020 (applications accepted through 2/5/2021)
National Institutes of Health (NIH)

NIDA

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus $100K direct costs/yr 3/19/2020 (applications accepted through 3/31/2021)
National Institutes of Health (NIH)

NIAID

 Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Must reflect your needs 3/25/2020 (applications accepted through 3/25/2021)
National Institutes of Health (NIH)

NIMH, NIA, NIAAA, NIMHD

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus Contact program officer 3/27/2020 (applications accepted through 4/15/2021)
National Institutes of Health (NIH)

NCATS

Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Check RFA(s) within 4/5/2020 (application deadlines through 4/5/2021)
National Institutes of Health


NIA, NIMH

Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) Must reflect your needs 4/6/2020 (applications accepted through 5/1/2021)
National Institutes of Health (NIH)
OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences $200,000 (direct costs) 4/13/2020 (applications accepted until 3/31/2021)
National Institutes of Health (NIH)
NCI
Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) $100,000 4/14/2020 (applications accepted through 6/26/2020)
National Institutes of Health (NIH)
Common Fund
NEWNotice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Budgets should not exceed the annual amount of the current parent award 4/15/2020 (applications accepted through 6/19/2020)
National Institutes of Health (NIH)
NIBIB Point-of-Care Technology Research Network (POCTRN)
Fast-Track Program for COVID-19 Test Development and Distribution) Phase 0: $25,000 Rolling (selection process began 4/29/2020)
National Institutes of Health (NIH)
NHLBI
NEWNotice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials Up to two years of support 5/1/2020 (applications accepted through 10/5/2020)
National Institutes of Health (NIH)
NIMHD, NIA, NIMH
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities $125,000 (direct costs) 5/1/2020 (applications accepted through 5/1/2021)
National Institutes of Health (NIH)
NIEHS
Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) Must reflect your needs 5/1/2020, 6/1/2020 (other deadlines within)
National Institutes of Health (NIH)

NCATS

Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need Must reflect your needs 5/4/2020 (other FOA deadlines within)
National Institutes of Health (NIH)

NCATS

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs Budgets must reflect the actual needs 5/4/2020 (applications accepted until 11/10/2020)
National Institutes of Health (NIH)

NIAID,NIA

Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) Not limited 5/13/2020; 9/13/2020; and others
National Institutes of Health (NIH)

NIAAA

Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA $200,000 (direct costs) 5/15/2020(applications accepted until 4/15/2021)
National Institutes of Health (NIH)

NCATS

Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus Limited to amount of current parent 5/15/2020 (applications accepted until 1/25/2022)
National Institutes of Health (NIH)

NCATS

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus Limited to no more than 25% total costs of the amount of the current parent award 5/15/2020 (applications accepted until 1/25/2022)
National Institutes of Health (NIH)

NCCIH, ORWH

NEWNotice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) $150,000 (direct cost)/td> 5/22/2020 (applications accepted through 8/17/2020)
National Institutes of Health (NIH)

NIDCR

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR $150,000 (direct costs) 6/1/2020 and 11/2/2020
National Institutes of Health (NIH)

NCATS

Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) Check RFA(s) within 6/5/2020 (other later deadlines within)
National Institutes of Health NIMHD, NEI, NHLBI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIMH, NCCIH, NCATS Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations $250,000 (direct costs) 6/10/2020 (applications accepted until 12/15/2020)
National Institutes of Health NIMH, NEI, NHLBI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NINR, NIMHD, NCCIH, NCATS Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 $200,000 (direct costs) 6/10/2020 (applications accepted until 12/15/2020)
National Institutes of Health NIAID NEWNotice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Varies (see three FOAs within) 6/16/2020 (subsequent receipt dates through 9/8/2021)
National Institutes of Health (NIH)

NIA

NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) Must reflect your needs 7/1/2020; 8/3/2020; and others
National Institutes of Health (NIH)
OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDA, NIEHS, NIGMS, NIMH, NINR, NLM, FIC, NCCIH, NCATS, NCI, NIAID, NIDDK, NIAAA, NINDS
Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) $20M (direct costs) Internal: 7/7/2020
National Institutes of Health (NIH)
OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NINDS, NIMH, NINR, NLM, FIC, NCCIH, NCATS, NCI
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations $700,000 7/8/2020 and 9/8/2020
National Institutes of Health (NIH)
OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, FIC, NCCIH, NCATS, NCI
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations $800,000 (direct costs) 7/8/2020 and 9/8/2020
National Institutes of Health (NIH)

Common Fund

NIH Director’s Emergency Early Independence Awards (DP5 Clinical Trial Optional) $1,250,000 (direct costs) Internal: 7/9/2020
National Institutes of Health (NIH)

OD, NHLBI, NHGRI, NIA, NIAID, NIAMS, NICHD, NIDCD, NIDCR, NIDDK, NIEHS, NINDS, NIMHD, NCCIH, NCATS, ORIP, NCI

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project $$1,000,000(direct costs) 7/13/2020; 11/12/2020; other deadlines within
National Institutes of Health (NIH)
NCI
Request for Proposals (RFP) Solicitation S20-119: Serological Sciences Network Capacity Building Centers unspecified 7/16/2020
National Institutes of Health (NIH)
NCI, NIAID
Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) $7,500,000 (direct costs) 7/22/2020
National Institutes of Health (NIH)
NCI, NIAID
Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) $2,500,000 (direct costs) 7/22/2020
National Institutes of Health (NIH)

NIMHD, NIA, NICHD, NIDCD, NIDCR, NIDA, NIEHS, NIMH, NINR, NCCIH,

Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) TBD 7/22/2020 (anticipated)
National Institutes of Health (NIH)

National Institutes of Health (NIH)

OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, NCCIH, NCATS, NCI

Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations $5M (total costs) 8/7/2020
National Institutes of Health (NIH)

NIMH, NEI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDA, NINR, NIMHD, NCCIH, NCATS

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 – Clinical Trial Optional $2,250,000 (direct costs) 8/20/2020
National Institutes of Health (NIH)

OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NINDS, NIMH, NINR, NLM, FIC, NCCIH, NCATS, NCI

Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) $2.5M (direct costs) 8/28/2020; 12/1/2020
National Institutes of Health (NIH)

Common Fund

NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional) Must reflect your needs 8/30/2020 (applications accepted through 9/30/2020)
National Institutes of Health (NIH)

NIAID

Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed) $275,000 (direct costs) 9/9/2020
National Institutes of Health (NIH)

NIDCD

Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders Varies (see RFAs within) 10/5/2020(subsequent receipt dates through 9/8/2022)/td>
National Institutes of Health (NIH)

NIMHD, NIA, NIDA, NCI

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) Not limited 10/5/2020 (and standard R01 deadlines)
National Institutes of Health (NIH)

NCATS

Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need Must reflect your needs Applications accepted until 11/10/2020
National Institutes of Health (NIH)

NIBIB

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) Up to two years of support- limited to no more than the amount of the current parent award Applications accepted on a rolling basis until 11/10/2020
National Institutes of Health (NIH)

NINDS

NEWSupplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System $200,000 (direct costs) Applications accepted until 4/14/2021
National Institutes of Health (NIH)

NIAID

NEWEmergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) $275,000 (direct costs) 4/30/2020 (Applications accepted until 4/30/2021)
National Institutes of Health (NIH)

NIAID

NEWEmergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) Budgets must reflect the actual needs 4/30/2020 (Applications accepted until 4/30/2021)
National Institutes of Health (NIH)

NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMHD, NIBIB,NCATS

Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) Not limited See Emergency Notice of Special Interest by IC
NSF Funding Opportunities

NSF COVID-19 FUNDING OPPORTUNITIES

SPONSOR PROGRAM FUNDING DEADLINE
National Science Foundation (NSF) RAPID: Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) $200,000 Check with program officers
PCORI Sponsor Funding Opportunities

PCORI COVID-19 FUNDING OPPORTUNITIES

SPONSOR PROGRAM FUNDING DEADLINE
Patient-Centered Outcomes
Research Institute (PCORI)
PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Research Projects $500,000 Applications accepted on a rolling basis
Patient-Centered Outcomes
Research Institute (PCORI)
PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Engagement Awards $150,000 Applications accepted on a rolling basis
Patient-Centered Outcomes
Research Institute (PCORI)
Phased Large Awards in Comparative Effectiveness Research (PLACER) $22M/td> LOI: 9/29/2020
Full app: 1/12/2021
Pfizer Funding Opportunities

There are currently no COVID-19 Funding Opportunities for Pfizer.

The Rheumatology Research Foundation

The Rheumatology Research Foundation COVID-19 FUNDING OPPORTUNITIES

SPONSOR PROGRAM FUNDING DEADLINE
The Rheumatology Research Foundation NEW<Scientist Development Award, Investigator Award & Innovative Research Award varies LOI: 6/1/2020
Full application: 7/1/2020
The Rheumatology Research Foundation NEWInnovative Research Award for Community Practitioners $400,000 LOI: 6/1/2020
Full application: 8/3/2020
Robert Wood Johnson Foundation (RWJF) Funding Opportunities

Robert Wood Johnson Foundation (RWJF) Funding Opportunities COVID-19 FUNDING OPPORTUNITIES

SPONSOR PROGRAM FUNDING DEADLINE
Robert Wood Johnson Foundation (RWJF) NEWEmergency Response for the Health Care System: Phase I unspecified 6/12/2020 (Phase I)
8/18/2020 (Phase II)
Robert Wood Johnson Foundation (RWJF) NEWEmergency Response for the General Public Innovation Challenge unspecified 6/12/2020 (Phase I)
8/18/2020 (Phase II)
Robert Wood Johnson Foundation (RWJF) NEWSystems for Action: Supplemental Research on COVID-19 Response and Recovery $200,000 8/5/2020